1978
DOI: 10.1289/ehp.7826269
|View full text |Cite
|
Sign up to set email alerts
|

Symposium on Target Organ Toxicity: cardiovascular system. The epidemiologic approach.

Abstract: Epidemiological studies rarely provide unequivocal data on the effects of toxic substances on human health. Unlike experimental studies, pertinent variables frequently cannot be controlled and some are often unknown. Nevertheless, these limitations can be dealt with by various facets of an epidemiological investigation. These include, the choice of a study design, selection of controls or comparison populations, evaluation of available data, statistical analysis, and the drawing of appropriate inferences from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1982
1982
2009
2009

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…Cardiovascular toxicity encompasses developmental malformations of cardiovascular system and it includes functional derangements like pump failure secondary to toxic effects of an agent. As a marker of cardiovascular toxicity, the status of diagnosable medical conditions like myocardial infarction and atheroscelerosis and precursor conditions like hypertension, dyslipedemia, and arrythmia is not established [24]. In a young population, the diagnosable endpoints like myocardial infarction or pump failure may not be appropriate criteria to judge cardiovascular toxicity, as these diagnoses are unlikely at this age.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiovascular toxicity encompasses developmental malformations of cardiovascular system and it includes functional derangements like pump failure secondary to toxic effects of an agent. As a marker of cardiovascular toxicity, the status of diagnosable medical conditions like myocardial infarction and atheroscelerosis and precursor conditions like hypertension, dyslipedemia, and arrythmia is not established [24]. In a young population, the diagnosable endpoints like myocardial infarction or pump failure may not be appropriate criteria to judge cardiovascular toxicity, as these diagnoses are unlikely at this age.…”
Section: Discussionmentioning
confidence: 99%